FDA Approved: LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024% — Original Application (Gland Pharma Limited)

View source ↗

Summary

The FDA approved a generic latanoprostene bunod ophthalmic solution, 0.024%, from Gland Pharma Limited under an Original Application. It is indicated for reduci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024% (latanoprostene bunod ophthalmic solution 0.024%)

Snippet

ORIG AP for LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024% (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024%)